DNA Earnings

Quarterly EPS
$-1.08
Q3 2024
$-2.00
Q4 2024
$-1.68
Q1 2025
$-1.10
Q2 2025
$-1.45
Q3 2025
$-1.41
Q4 2025
$-1.39
Q1 2026
$-0.75
Q2 2026
Latest Revenue20.2M
Latest Net Income-46710000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.7520.2M-46710000-48.5%+31.8%
Q1 2026-$1.3919.5M-82587000-49.1%+17.3%
Q4 2025-$1.4133.4M-80751000-23.8%+29.5%
Q3 2025-$1.4538.8M-80755000-56.4%-34.3%
Q2 2025-$1.1039.1M-60300000-30.4%+74.0%
Q1 2025-$1.6838.2M-90957000+0.8%+49.2%
Q4 2024-$2.0043.8M-107534000+26.2%+8.3%
Q3 2024-$1.0889.0M-56403000+60.6%+82.6%
Q2 2024-$4.2356.2M-217181000
Q1 2024-$3.3137.9M-165911000
Q4 2023-$2.1834.8M-211694000
Q3 2023-$6.2155.4M-302891000
Ginkgo Bioworks (DNA) — Earnings